Treatment Arm
Visit vs Sp02: Saturation Less than 90%
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Baseline | 316 | 9.9 | ± 13.4 | 5.1 | 0.0 | 81.9 | 2 | 318 |
| Final | 275 | 6.5 | ± 12.7 | 1.7 | 0.0 | 87.3 | 26 | 301 |
Treatment Arm vs Sp02: Saturation Less than 90%
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 316 | 9.9 | ± 13.4 | 5.1 | 0.0 | 81.9 | 2 | 318 |
| HLSE | 106 | 9.7 | ± 12.5 | 5.8 | 0.0 | 78.2 | - | 106 |
| HLSE-O | 105 | 10.1 | ± 12.7 | 5.9 | 0.0 | 74.4 | 1 | 106 |
| HLSE-P | 105 | 9.8 | ± 15.0 | 3.8 | 0.0 | 81.9 | 1 | 106 |
Treatment Arm vs Sp02: Saturation Less than 90%
Final
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 275 | 6.5 | ± 12.7 | 1.7 | 0.0 | 87.3 | 25 | 300 |
| HLSE | 94 | 9.7 | ± 14.9 | 4.5 | 0.0 | 87.3 | 6 | 100 |
| HLSE-O | 95 | 4.5 | ± 9.0 | 0.6 | 0.0 | 48.6 | 6 | 101 |
| HLSE-P | 86 | 5.3 | ± 13.1 | 0.6 | 0.0 | 84.8 | 13 | 99 |
Age vs Sp02: Saturation Less than 90%
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 316 | 9.9 | ± 13.4 | 5.1 | 0.0 | 81.9 | 2 | 318 |
| 45-54 years | 52 | 8.3 | ± 9.6 | 5.0 | 0.0 | 45.7 | 1 | 53 |
| 55-64 years | 139 | 10.7 | ± 14.8 | 5.1 | 0.0 | 81.9 | - | 139 |
| 65-74 years | 120 | 9.4 | ± 13.1 | 5.1 | 0.0 | 78.2 | 1 | 121 |
| 75 or older | 5 | 12.0 | ± 16.4 | 8.9 | 0.1 | 40.0 | - | 5 |
Age vs Sp02: Saturation Less than 90%
Final
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 275 | 6.5 | ± 12.7 | 1.7 | 0.0 | 87.3 | 25 | 300 |
| 45-54 years | 42 | 4.9 | ± 7.9 | 2.4 | 0.0 | 41.4 | 7 | 49 |
| 55-64 years | 117 | 7.4 | ± 14.0 | 1.5 | 0.0 | 84.8 | 10 | 127 |
| 65-74 years | 112 | 6.0 | ± 12.6 | 1.6 | 0.0 | 87.3 | 7 | 119 |
| 75 or older | 4 | 11.7 | ± 17.2 | 4.8 | 0.0 | 37.1 | 1 | 5 |
Gender vs Sp02: Saturation Less than 90%
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 316 | 9.9 | ± 13.4 | 5.1 | 0.0 | 81.9 | 2 | 318 |
| Male | 232 | 9.0 | ± 12.0 | 5.1 | 0.0 | 78.2 | 2 | 234 |
| Female | 84 | 12.2 | ± 16.6 | 5.4 | 0.0 | 81.9 | - | 84 |
Gender vs Sp02: Saturation Less than 90%
Final
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 275 | 6.5 | ± 12.7 | 1.7 | 0.0 | 87.3 | 26 | 301 |
| Male | 202 | 6.1 | ± 12.0 | 1.6 | 0.0 | 87.3 | 20 | 222 |
| Female | 73 | 7.6 | ± 14.5 | 1.9 | 0.0 | 84.8 | 6 | 79 |
Race vs Sp02: Saturation Less than 90%
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 316 | 9.9 | ± 13.4 | 5.1 | 0.0 | 81.9 | 2 | 318 |
| African American or Black | 41 | 8.5 | ± 12.5 | 4.2 | 0.0 | 64.6 | 1 | 42 |
| Caucasian | 251 | 10.4 | ± 13.8 | 5.6 | 0.0 | 81.9 | 1 | 252 |
| Other | 24 | 6.7 | ± 10.4 | 2.7 | 0.1 | 43.6 | - | 24 |
Race vs Sp02: Saturation Less than 90%
Final
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 275 | 6.5 | ± 12.7 | 1.7 | 0.0 | 87.3 | 25 | 300 |
| African American or Black | 34 | 3.4 | ± 7.1 | 1.1 | 0.0 | 36.0 | 6 | 40 |
| Caucasian | 219 | 7.3 | ± 13.8 | 1.8 | 0.0 | 87.3 | 18 | 237 |
| Other | 22 | 3.2 | ± 3.3 | 2.3 | 0.0 | 10.3 | 1 | 23 |